Physician profile

Marcus A Frey

Podiatrist · Ocala, FL

NPI 1346521150

$1,244.06

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$246.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Organogenesis INC. $486.51 2019-2024 Apligraf, Puraply Wound Matrix, Nushield
Smith+Nephew, INC. $219.91 2019-2022
Wright Medical Technology, INC. $204.97 2020
Integra Lifesciences Corporation $126.57 2019
Horizon Therapeutics Plc $101.40 2019-2020
Acera Surgical, INC. $52.48 2022
Misonix INC $23.91 2020
Kerecis Limited $15.43 2022
Convatec INC. $12.88 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marcus A Frey

$1,244.06

in general payments reported 2019-2025

Years
2019-2024
Top company
Organogenesis INC.

https://glasscript.com/doctor/288115/marcus-a-frey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.